Targeting autophagy to sensitive glioma to temozolomide treatment

Temozolomide (TMZ), an alkylating agent, is widely used for treating primary and recurrent high-grade gliomas. However, the efficacy of TMZ is often limited by the development of resistance. Recently, studies have found that TMZ treatment could induce autophagy, which contributes to therapy resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Yuanliang, Xu, Zhijie, Dai, Shuang, Qian, Long, Sun, Lunquan, Gong, Zhicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736617/
https://www.ncbi.nlm.nih.gov/pubmed/26830677
http://dx.doi.org/10.1186/s13046-016-0303-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736617/
https://www.ncbi.nlm.nih.gov/pubmed/26830677
http://dx.doi.org/10.1186/s13046-016-0303-5

Ejemplares similares